Research programme: colon cancer therapies - Biogen Idec/Caprion
Alternative Names: Colon cancer therapies research programme - Biogen Idec/CaprionLatest Information Update: 22 Jun 2007
Price :
$50 *
At a glance
- Originator Biogen Idec; Caprion Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer